Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05906082 · ClinicalTrials.gov registry record · NA
Vape-Free Text-Messaging: Pilot Study
A NA study of E-cigarette Use, sponsored by Jovan Gwon, PhD, RN, FIAAN.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT05906082: Recruiting NA study of E-cigarette Use, sponsored by Jovan Gwon, PhD, RN, FIAAN.
NCT05906082 is a NA study of E-cigarette Use that is actively recruiting participants, run by Jovan Gwon, PhD, RN, FIAAN. The registered enrollment target is 50 participants, below the 200-participant average among 12 other E-cigarette Use trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05906082, a NA study of E-cigarette Use, is actively recruiting participants, sponsored by Jovan Gwon, PhD, RN, FIAAN.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a small pilot randomized controlled trial to evaluate the feasibility, acceptability, and preliminary efficacy of the e-cigarette cessation text-messaging intervention with young adults in rural areas.
Primary Outcome
Number of participants recruited and randomized
Conditions Studied
Interventions
- BEHAVIORAL E-cigarette cessation text-messaging intervention
- BEHAVIORAL Standard care control using standard national resources
Study Locations (1)
Wisconsin
- University of Wisconsin-Milwaukee - Milwaukee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2023-05-25 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
What NCT05906082 shows while recruiting
NCT05906082 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 200-participant average among 12 other E-cigarette Use trials with a reported enrollment target (75% lower).
The record links to 1 condition, with E-cigarette Use appearing as the primary indexed condition, and to 2 interventions - of which E-cigarette cessation text-messaging intervention is the first listed.
NCT05906082 reports a single indexed study location in Wisconsin.
Frequently Asked Questions
What is clinical trial NCT05906082 about?
NCT05906082 is a clinical study titled "Vape-Free Text-Messaging: Pilot Study". This is a small pilot randomized controlled trial to evaluate the feasibility, acceptability, and preliminary efficacy of the e-cigarette cessation text-messaging intervention with young adults in rural areas.
What is the current status of trial NCT05906082?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2023-05-25. Estimated completion is 2026-12-31.
What conditions does trial NCT05906082 study?
This clinical trial studies the following conditions: E-cigarette Use.
What interventions are being tested in trial NCT05906082?
The interventions under investigation include: E-cigarette cessation text-messaging intervention (BEHAVIORAL), Standard care control using standard national resources (BEHAVIORAL).
Who is sponsoring clinical trial NCT05906082?
This trial is sponsored by Jovan Gwon, PhD, RN, FIAAN, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05906082 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for E-cigarette Use
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05906082's enrollment target sits among peer trials
50 10th of 12 higher than 3 of 12 other E-cigarette Use trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other E-cigarette Use trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effects of a Low Nicotine Standard and Tobacco Prices on Illegal Cigarette Purchasing
RECRUITING · NA
-
Noncombustible Nicotine Delivery Systems as Potential Harm Reduction Tools for Persistent Cigarette Smokers
RECRUITING · NA
-
An Online Intervention to Reduce E-cigarette Use and Susceptibility to Smoking in Young Adults
RECRUITING · NA
-
Adapting an Intervention for Vaping in Young Veterans
RECRUITING · NA
-
Tobacco Product Susceptibility and Substitutability by Rurality and Alcohol Use
COMPLETED · NA
-
PACE Vape Messaging Study
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI